Stock code: 301035 Stock abbreviation: Rainbow Agro Announcement No.: 2025-046 SHANDONG WEIFANG RAINBOW CHEMICAL CO., LTD The Semi-Annual Financial Report of 2025 The Company and all members of the Board of Directors warrant that the information disclosed is true, accurate, and complete, without false records, misleading statements, or material omissions. 1. Consolidated balance sheet Prepared by: Shandong Weifang Rainbow Chemical Co., Ltd June 30, 2025 | | | Unit: RMB | | --- | --- | --- | | Item | Closing ...

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company's operational quality continues to improve, with the Model C business gaining traction. The industry is experiencing a recovery in demand, leading to a gradual normalization of market prices [7][8] - The company reported significant growth in its financial performance, with a revenue of 6.53 billion yuan in H1 2025, representing a year-on-year increase of 15%. The net profit attributable to the parent company reached 556 million yuan, a year-on-year increase of 206% [7] - The company aims to become a global leader in crop protection, enhancing its global marketing network and product registration efforts [7] Financial Data and Profit Forecast - Total revenue projections for the company are as follows: 14.65 billion yuan in 2025, 16.02 billion yuan in 2026, and 17.59 billion yuan in 2027, with respective growth rates of 10.1%, 9.4%, and 9.8% [6] - The net profit attributable to the parent company is forecasted to be 1.15 billion yuan in 2025, 1.40 billion yuan in 2026, and 1.69 billion yuan in 2027, with significant year-on-year growth rates of 155.2%, 21.7%, and 21.0% respectively [6][8] - The company's gross margin is expected to improve, reaching 21.9% in 2025 and 23.3% in 2027 [6]

Investment Rating - The investment rating for the company is "Buy" and it is maintained [10] Core Views - The company reported a revenue of 6.53 billion yuan for the first half of 2025, representing a year-on-year increase of 14.9%. The net profit attributable to shareholders was 560 million yuan, up 205.6% year-on-year, and the net profit excluding non-recurring items was 550 million yuan, an increase of 211.9% year-on-year [2][7] - In Q2 2025, the company achieved a revenue of 3.84 billion yuan, reflecting a year-on-year growth of 28.6% and a quarter-on-quarter increase of 43.1%. The net profit attributable to shareholders reached 300 million yuan, a staggering year-on-year increase of 932.3% and a quarter-on-quarter increase of 16.4% [2][7] - The company plans to distribute a cash dividend of 3.5 yuan per 10 shares (tax included) [2][7] Company Overview - The company is a leading player in the domestic pesticide formulation industry, with R&D teams and centers located in Jinan and Weifang, Shandong. It operates six manufacturing bases across China and internationally, including in Argentina, Spain, and the USA [12] - The global pesticide market is expected to continue its steady growth, supported by strong demand for crop protection products. The company has seen a significant increase in its gross margin to 22.9% in Q2 2025, up 2.6 percentage points year-on-year, and a net margin of 9.1%, up 7.4 percentage points year-on-year [12] - The company has established a "fast market entry platform" to expand its market share and has increased its revenue from TOC (local team sales of proprietary brands) to 41.35% of total revenue, up from 37.84% year-on-year [12] Financial Projections - The company forecasts net profits attributable to shareholders of 1.1 billion yuan, 1.52 billion yuan, and 1.97 billion yuan for the years 2025, 2026, and 2027, respectively [12]

Core Viewpoint - The company has shown significant growth in its agricultural chemical products, with strong performance in the first half of 2025, driven by increased exports and strategic business focus [2][3]. Group 1: Financial Performance - Agricultural chemical product exports increased by 17.07% year-on-year in the first half of 2025, with a 22.67% increase in the second quarter [2] - The company's revenue grew by 14.94% year-on-year in the first half, while net profit surged by 205.62% [2] - Cash flow from operating activities increased by 743.73% year-on-year in the first half of 2025 [2] - In the second quarter, revenue rose by 28.64%, net profit increased by 932.30%, and cash flow grew by 502.86% [2] Group 2: Strategic Focus and Business Growth - The company is focusing on four growth directions, with TO C business revenue share rising to 40.14% and gross margin increasing to 30.21% [3] - Revenue from EU and North America markets increased to 14.08% of total revenue [3] - The insecticide and fungicide business revenue share rose to 26.59% [3] - The company has registered over 600 new products in the first half of 2025, totaling more than 8,400 registrations [3] Group 3: Operational Challenges and Global Expansion - The company acknowledged that 2025 is a transitional year, with performance affected by exchange rates and previous strategic execution issues [4] - Effective cost control measures are in place, although overseas expenses have increased due to the rise in Model C business and adjustments in operational management [4] - The company is in the learning phase of building a global operational management system, which is identified as a key task for future growth [4] - Discussions during the meeting included industry trends, market conditions, product planning, and progress in raw material manufacturing [4]

Group 1 - The company expresses a cautiously optimistic outlook for its annual performance, expecting revenue, gross margin, and net profit attributable to shareholders to show a year-on-year increase [1] - There are uncertainties regarding the exact percentage of year-on-year growth [1]

Group 1: Export Performance - The total export quantity under HS code 3808 increased by 17.07% year-on-year in the first half of 2025, with a significant increase of 22.67% in the second quarter [4] - The total export value under HS code 3808 increased by 13.72% year-on-year in the first half of 2025, with a 20.69% increase in the second quarter [4] - The average export price (USD/Kg) remained stable, with a slight decrease from USD 2.87/Kg in January to USD 2.85/Kg in April 2025 [4] Group 2: Financial Performance - The company's revenue in the first half of 2025 grew by 14.94% year-on-year, while net profit attributable to shareholders increased by 205.62% [4] - In the second quarter, revenue grew by 28.64% year-on-year, and net profit increased by 932.30% [4] - Cash flow from operating activities increased by 743.73% in the first half of 2025 [4] Group 3: Strategic Focus - The company aims to increase the proportion of TO C business, which rose from 37.52% in the first half of 2024 to 40.14% in the reporting period [5] - The revenue share from the EU and North America increased from 11.42% in the first half of 2024 to 14.08% [5] - The revenue share from insecticides and fungicides increased from 24.15% in the first half of 2024 to 26.59% [5] Group 4: Operational Quality - The company has adjusted performance targets to focus on quality improvement, increasing the weight of operational quality indicators such as gross margin and overdue accounts [8] - The company has established a global operational management system (GMS) to enhance operational capabilities [7] - The company aims to improve operational quality while maintaining stable revenue growth [8] Group 5: Market Trends - The agricultural chemical industry has shown resilience, with exports from China and India continuing to grow despite market challenges [24] - The preference for cost-effective non-patented products has increased, leading to a shift in purchasing habits towards reduced inventory and fragmented procurement [23] - The company anticipates cautious optimism for overall performance in 2025, with expected increases in revenue, gross margin, and net profit [14] Group 6: Global Expansion - The company has plans for deeper market penetration in India, with ongoing registration of active ingredients and formulations [29] - The focus on building a global operational management system is seen as crucial for sustainable growth [21] - The company recognizes the need for effective management and integration of overseas operations to mitigate risks [30]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 86.10 CNY, based on a projected PE ratio of 21 times for 2025 [2][5]. Core Insights - The company's earnings per share (EPS) are forecasted to be 4.10 CNY, 4.89 CNY, and 5.94 CNY for the years 2025, 2026, and 2027 respectively, indicating a strong recovery and growth trajectory [2]. - The report highlights significant improvements in operational performance, with a notable increase in revenue and net profit in the second quarter, driven by structural optimization and enhanced profitability [10]. - The company has strengthened its risk control capabilities in overseas operations, achieving a net operating cash flow of 960 million CNY in the second quarter, marking the best quarterly performance in nearly two years [10]. Financial Information Summary - Revenue projections for the company are as follows: - 2023: 11,485 million CNY - 2024: 13,296 million CNY (15.8% YoY growth) - 2025: 15,073 million CNY (13.4% YoY growth) - 2026: 17,376 million CNY (15.3% YoY growth) - 2027: 19,900 million CNY (14.5% YoY growth) [4] - The company's gross profit margin is expected to improve from 21.2% in 2023 to 21.9% in 2027, reflecting ongoing structural enhancements [4]. - The net profit attributable to the parent company is projected to recover significantly, with estimates of 1,152 million CNY in 2025, 1,372 million CNY in 2026, and 1,668 million CNY in 2027, showcasing a strong growth trend [4].

Core Viewpoint - Runfeng Co., Ltd. (301035) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the same period in 2024 [1][2]. Financial Performance - Total revenue reached 6.531 billion yuan, a year-on-year increase of 14.94% [1] - Net profit attributable to shareholders was 555.6 million yuan, up 205.62% year-on-year [1] - In Q2 2025, total revenue was 3.844 billion yuan, reflecting a 28.64% increase year-on-year, while net profit for the quarter was 299 million yuan, soaring 932.3% [1] - Gross margin improved to 21.42%, up 5.89% year-on-year, and net margin increased to 9.56%, a rise of 151% [1] - Total expenses (selling, administrative, and financial) amounted to 326 million yuan, accounting for 4.99% of revenue, down 64.14% year-on-year [1] Key Financial Metrics - Earnings per share (EPS) reached 2.0 yuan, a 207.69% increase year-on-year [1] - Operating cash flow per share was 3.18 yuan, up 738.89% year-on-year [1] - The company's return on invested capital (ROIC) was 6.37% last year, indicating average capital returns [2] - The company’s historical median ROIC since listing is 7.63%, suggesting generally average investment returns [2] Cash Flow and Debt Management - Cash flow from operating activities saw a significant increase of 743.73%, attributed to higher sales collections [2] - The company’s monetary funds increased to 3.293 billion yuan, a 5.49% rise year-on-year, while interest-bearing debt decreased by 27.22% to 2.475 billion yuan [1][2] Fund Holdings - The largest fund holding Runfeng shares is the Jiao Yin Trend Mixed A fund, managed by Yang Jinjing, which has a total scale of 3.822 billion yuan [4] - Notable changes in fund holdings include increased positions in several funds, while some funds reduced their holdings [4]

Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, with revenue reaching 6.531 billion yuan, a year-on-year growth of 14.94%, and net profit of 555.6 million yuan, up 205.62% from 182 million yuan in the same period last year [2] - The company announced a mid-term dividend plan, proposing a cash dividend of 3.5 yuan per 10 shares (tax included) [2] - The crop protection industry is currently at the bottom of the cycle but shows signs of recovery, with leading companies like the one in question benefiting more clearly from this recovery [2] Business Segments - The herbicide segment remains the main revenue driver, generating 4.705 billion yuan in the first half of the year [2] - The company is optimizing its business structure, with the insecticide and fungicide segments showing strong growth, increasing their revenue share from 24.15% in the first half of 2024 to 26.59% in the reporting period [2] Market Expansion - The company's TO C (direct-to-consumer) business revenue share increased from 37.52% in the first half of 2024 to 40.14%, with gross margin rising from 29.21% to 30.21%, indicating improved profitability in direct customer-facing operations [2] - Internationally, the company expanded its market share in the EU and North America, with revenue share increasing from 11.42% in the first half of 2024 to 14.08% [3] - The biopesticide segment is also expanding into more countries across Africa, Asia, and the Americas, contributing to future growth [3] Future Outlook - The company has laid a solid foundation for future development through proactive product planning and continued investment in global registration, having obtained over 600 new registrations in the first half of 2025, totaling over 8,400 pesticide registration certificates domestically and internationally as of June 30, 2025 [3] - Despite uncertainties from trade protectionism in multiple countries, the company is expected to maintain a positive development trend in the pesticide industry due to recovering end-market prices and gross margins, favorable industry policies, and its optimized business structure and strong R&D registration capabilities [3]

2025年8月22日，润丰股份(301035.SZ)发布2025年中报。 公司营业总收入为65.31亿元，较去年同报告期营业总收入增加8.49亿元，实现2年连续上涨，同比较去 年同期上涨14.94%。归母净利润为5.56亿元，较去年同报告期归母净利润增加3.74亿元，同比较去年同 期上涨205.62%。经营活动现金净流入为8.93亿元，较去年同报告期经营活动现金净流入增加10.32亿 元，实现2年连续上涨。 公司摊薄每股收益为2.00元，较去年同报告期摊薄每股收益增加1.35元，同比较去年同期上涨 207.69%。 公司最新总资产周转率为0.41次，较去年同期总资产周转率增加0.04次，同比较去年同期上涨9.77%。 最新存货周转率为1.77次，较去年同期存货周转率增加0.51次，同比较去年同期上涨40.91%。 公司股东户数为6828户，前十大股东持股数量为2.28亿股，占总股本比例为81.16%，前十大股东持股情 况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | I | 山东润源投资有限公司 | 40.93% | | 2 | KONKIA INC | 21.7 ...